Chronic kidney failure
Semaglutide Reduces Risk of Major Kidney Outcomes in Type 2 Diabetes Patients
New research conducted by investigators at the University of Chicago Medicine has found that semaglutide, a medication used to treat type 2 diabetes, significantly reduces the risk of major kidney outcomes and all-cause mortality in patients with chronic kidney disease. The study, which was supported by Novo Nordisk A/S,